Firmenbeschreibung
Regeneron Pharmaceuticals, Inc. ist ein biopharmazeutisches Unternehmen. Der Konzern erforscht, entwickelt, produziert und vermarktet Medikamente zur Behandlung schwerer Erkrankungen mit Fokus auf humane Antikörpertechnologien. Regeneron Pharmaceuticals vermarktet drei Produkte in den USA: EYLEA® (aflibercept) Injektion zur Behandlung der feuchten altersbedingten Makula-Degeneration der Augen, ZALTRAP® (ziv-aflibercept) Injektion in Zusammenarbeit mit Sanofi zur Behandlung von Patienten mit metastatischem kolorektalem Krebs und ARCALYST® (rilonacept) Injektion zur Senkung der Harnsäure bei Gichtpatienten zur Vorbeugung von Gichtanfällen. Weitere Produktkandidaten befinden sich in Forschungs- und Entwicklungsprogrammen zur Behandlung von Entzündungen, Krebs und Hypercholesterinämie.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Fidelity Management & Research Co (7.97%),The Vanguard Group, Inc. (7.81%),BlackRock Fund Advisors (5.58%),Capital Research & Management Co (5.14%),JPMorgan Investment Management (4.65%),SSgA Funds Management, Inc. (4.63%),Capital Research & Management Co (2.74%),Dodge & Cox (2.22%),Geode Capital Management LLC (2.11%),T. Rowe Price Associates, Inc. (1.95%) |
| sharesOutstanding: | 107128838.0000 |
| ceo: | Dr. Leonard S. Schleifer |
| board: | Robert E. Landry, Dr. George D. Yancopoulos |
| supervisoryBoard: | Arthur F. Ryan, Christine A. Poon, Craig B. Thompson, Dr. Bonnie L. Bassler, Dr. George D. Yancopoulos, Dr. Leonard S. Schleifer, Dr. Marc Tessier-Lavigne, George L. Sing, Huda Y. Zoghbi, M.D., Joseph L. Goldstein, M.D., Michael S. Brown, M.D., Tony Coles, M.D. |
| countryID: | 20 |
| freeFloat: | 68.4000 |
| faceValue: | 0.0010 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Biotechnologie |
| industryName: | Biotechnologie |
| subsectorName: | Biotechnologie |
| country: | USA |
| countryName: | USA |
Kontakt
| phone: | +1-914-847-7741 |
| email: | invest@regeneron.com |
| irWebSite: | https://investor.regeneron.com |
Adresse
| street: | 777 Old Saw Mill River Road |
| city: | Tarrytown, New York 10591-6707, USA |
| phone: | +1-914-847-7000 |
| webSite: | is.gd/sEAmh8 |
Finanzen (kurz)
| year: | 2020 | cash: | 2193.7000 |
| balanceSheetTotal: | 17163.3000 | liabilities: | 6138.0000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 11025.3000 |
| sales: | 8497.1000 | incomeBeforeTaxes: | 3810.4000 |
| netIncome: | 3513.2000 | cashFlow: | 577.0000 |
| employees: | 9123 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2021 | cash: | 2885.6000 |
| balanceSheetTotal: | 25434.8000 | liabilities: | 6666.0000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 18768.8000 |
| sales: | 16071.7000 | incomeBeforeTaxes: | 9325.8000 |
| netIncome: | 8075.3000 | cashFlow: | 690.8000 |
| employees: | 10368 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 3105.9000 |
| balanceSheetTotal: | 29214.5000 | liabilities: | 6550.5000 |
| shareCapital: | 0.1000 | totalShareholdersEquity: | 22664.0000 |
| sales: | 12172.9000 | incomeBeforeTaxes: | 4858.8000 |
| netIncome: | 4338.4000 | cashFlow: | 221.3000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2020 |
| cash: | 2193.7000 |
| balanceSheetTotal: | 17163.3000 |
| liabilities: | 6138.0000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 11025.3000 |
| sales: | 8497.1000 |
| incomeBeforeTaxes: | 3810.4000 |
| netIncome: | 3513.2000 |
| cashFlow: | 577.0000 |
| employees: | 9123 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2021 |
| cash: | 2885.6000 |
| balanceSheetTotal: | 25434.8000 |
| liabilities: | 6666.0000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 18768.8000 |
| sales: | 16071.7000 |
| incomeBeforeTaxes: | 9325.8000 |
| netIncome: | 8075.3000 |
| cashFlow: | 690.8000 |
| employees: | 10368 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 3105.9000 |
| balanceSheetTotal: | 29214.5000 |
| liabilities: | 6550.5000 |
| shareCapital: | 0.1000 |
| totalShareholdersEquity: | 22664.0000 |
| sales: | 12172.9000 |
| incomeBeforeTaxes: | 4858.8000 |
| netIncome: | 4338.4000 |
| cashFlow: | 221.3000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 | units: | 1000000 |
| balanceSheetTotal: | 25434.8000 | cash: | 2885.6000 |
| currentAssets: | 14014.9000 | fixedAssets: | 11419.9000 |
| liabilities: | 3932.5000 | totalLiabilitiesEquity: | 25434.8000 |
| totalShareholdersEquity: | 18768.8000 | employees: | 10368 |
| property: | 3482.2000 | longTermInvestments: | 6838.0000 |
| inventories: | 1951.3000 | accountsReceivable: | 6036.5000 |
| currentSecurities: | 2809.1000 | accountsPayable: | 564.0000 |
| liabilitiesTotal: | 6666.0000 | longTermDebt: | 1980.0000 |
| shortTermDebt: | 719.7000 | commonStock: | 0.1000 |
| preferredStock: | 0.0000 | sales: | 16071.7000 |
| netIncome: | 8075.3000 | operatingResult: | 8946.8000 |
| incomeInterest: | -57.3000 | investments: | 2908.1000 |
| incomeTaxes: | 1250.5000 | costGoodsSold: | 3544.2000 |
| grossProfit: | 12527.5000 | revenuePerEmployee: | 1550125.3858 |
| cashFlow: | 7081.3000 | cashFlowInvesting: | -5384.7000 |
| cashFlowFinancing: | -1005.8000 | cashFlowTotal: | 690.8000 |
| accountingStandard: | US GAAP | equityRatio: | 73.7918 |
| debtEquityRatio: | 35.5164 | liquidityI: | 144.8112 |
| liquidityII: | 298.3140 | netMargin: | 50.2455 |
| grossMargin: | 77.9476 | cashFlowMargin: | 44.0607 |
| ebitMargin: | 55.6680 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 49.6878 | preTaxROA: | 36.6655 |
| roe: | 43.0251 | roa: | 31.7490 |
| netIncomeGrowth: | 129.8560 | revenuesGrowth: | 89.1434 |
| taxExpenseRate: | 13.4090 | equityTurnover: | 0.8563 |
| epsBasic: | 76.4000 | epsDiluted: | 71.9700 |
| epsBasicGrowth: | 133.9969 | shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 9325.8000 | priceEarningsRatioCompany: | 8.2660 |
| priceCashFlowRatio: | 9.5171 | bookValuePerShare: | 175.8762 |
| marketCap: | 67393287688.4800 | earningsYield: | 12.0978 |
| pegRatio: | 0.0617 | cashFlowPerShare: | 66.3565 |
| priceBookValueRatio: | 3.5907 | priceEarningsRatio: | 8.3456 |
| netEarningsPerShare: | 75.6709 | currency: | USD |
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 29214.5000 | cash: | 3105.9000 |
| currentAssets: | 15884.1000 | fixedAssets: | 13330.4000 |
| liabilities: | 3141.3000 | totalLiabilitiesEquity: | 29214.5000 |
| totalShareholdersEquity: | 22664.0000 | property: | 3763.0000 |
| intangibleAssets: | 915.5000 | longTermInvestments: | 6591.8000 |
| inventories: | 2401.9000 | accountsReceivable: | 5328.7000 |
| accountsPayable: | 589.2000 | liabilitiesTotal: | 6550.5000 |
| longTermDebt: | 2701.4000 | shortTermDebt: | 0.0000 |
| commonStock: | 0.1000 | preferredStock: | 0.0000 |
| sales: | 12172.9000 | netIncome: | 4338.4000 |
| operatingResult: | 4738.9000 | incomeInterest: | -59.4000 |
| investments: | 3592.5000 | incomeTaxes: | 520.4000 |
| costGoodsSold: | 1560.4000 | grossProfit: | 10612.5000 |
| cashFlow: | 5014.9000 | cashFlowInvesting: | -3784.6000 |
| cashFlowFinancing: | -1009.0000 | cashFlowTotal: | 221.3000 |
| accountingStandard: | US GAAP | equityRatio: | 77.5779 |
| debtEquityRatio: | 28.9027 | liquidityI: | 98.8731 |
| liquidityII: | 268.5067 | netMargin: | 35.6398 |
| grossMargin: | 87.1814 | cashFlowMargin: | 41.1972 |
| ebitMargin: | 38.9299 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 21.4384 | preTaxROA: | 16.6315 |
| roe: | 19.1423 | roa: | 14.8502 |
| netIncomeGrowth: | -46.2757 | revenuesGrowth: | -24.2588 |
| taxExpenseRate: | 10.7105 | equityTurnover: | 0.5371 |
| epsBasic: | 40.5100 | epsDiluted: | 38.2200 |
| epsBasicGrowth: | -46.9764 | shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 4858.8000 | priceEarningsRatioCompany: | 17.8102 |
| priceCashFlowRatio: | 15.4670 | bookValuePerShare: | 210.8134 |
| marketCap: | 77565503925.1400 | earningsYield: | 5.6148 |
| pegRatio: | -0.3791 | cashFlowPerShare: | 46.6470 |
| priceBookValueRatio: | 3.4224 | priceEarningsRatio: | 17.8788 |
| netEarningsPerShare: | 40.3544 | currency: | USD |
| year: | 2023 | priceEarningsRatioCompany: | 20.1150 |
| priceCashFlowRatio: | 17.4686 | bookValuePerShare: | 210.8134 |
| marketCap: | 88776539382.2400 | earningsYield: | 4.9714 |
| pegRatio: | -0.4282 | cashFlowPerShare: | 46.6470 |
| netAssetsPerShare: | 210.8134 | priceBookValueRatio: | 3.8653 |
| priceEarningsRatio: | 20.1926 | netEarningsPerShare: | 40.3544 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 |
| units: | 1000000 |
| balanceSheetTotal: | 25434.8000 |
| cash: | 2885.6000 |
| currentAssets: | 14014.9000 |
| fixedAssets: | 11419.9000 |
| liabilities: | 3932.5000 |
| totalLiabilitiesEquity: | 25434.8000 |
| totalShareholdersEquity: | 18768.8000 |
| employees: | 10368 |
| property: | 3482.2000 |
| longTermInvestments: | 6838.0000 |
| inventories: | 1951.3000 |
| accountsReceivable: | 6036.5000 |
| currentSecurities: | 2809.1000 |
| accountsPayable: | 564.0000 |
| liabilitiesTotal: | 6666.0000 |
| longTermDebt: | 1980.0000 |
| shortTermDebt: | 719.7000 |
| commonStock: | 0.1000 |
| preferredStock: | 0.0000 |
| sales: | 16071.7000 |
| netIncome: | 8075.3000 |
| operatingResult: | 8946.8000 |
| incomeInterest: | -57.3000 |
| investments: | 2908.1000 |
| incomeTaxes: | 1250.5000 |
| costGoodsSold: | 3544.2000 |
| grossProfit: | 12527.5000 |
| revenuePerEmployee: | 1550125.3858 |
| cashFlow: | 7081.3000 |
| cashFlowInvesting: | -5384.7000 |
| cashFlowFinancing: | -1005.8000 |
| cashFlowTotal: | 690.8000 |
| accountingStandard: | US GAAP |
| equityRatio: | 73.7918 |
| debtEquityRatio: | 35.5164 |
| liquidityI: | 144.8112 |
| liquidityII: | 298.3140 |
| netMargin: | 50.2455 |
| grossMargin: | 77.9476 |
| cashFlowMargin: | 44.0607 |
| ebitMargin: | 55.6680 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 49.6878 |
| preTaxROA: | 36.6655 |
| roe: | 43.0251 |
| roa: | 31.7490 |
| netIncomeGrowth: | 129.8560 |
| revenuesGrowth: | 89.1434 |
| taxExpenseRate: | 13.4090 |
| equityTurnover: | 0.8563 |
| epsBasic: | 76.4000 |
| epsDiluted: | 71.9700 |
| epsBasicGrowth: | 133.9969 |
| shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 9325.8000 |
| priceEarningsRatioCompany: | 8.2660 |
| priceCashFlowRatio: | 9.5171 |
| bookValuePerShare: | 175.8762 |
| marketCap: | 67393287688.4800 |
| earningsYield: | 12.0978 |
| pegRatio: | 0.0617 |
| cashFlowPerShare: | 66.3565 |
| priceBookValueRatio: | 3.5907 |
| priceEarningsRatio: | 8.3456 |
| netEarningsPerShare: | 75.6709 |
| currency: | USD |
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 29214.5000 |
| cash: | 3105.9000 |
| currentAssets: | 15884.1000 |
| fixedAssets: | 13330.4000 |
| liabilities: | 3141.3000 |
| totalLiabilitiesEquity: | 29214.5000 |
| totalShareholdersEquity: | 22664.0000 |
| property: | 3763.0000 |
| intangibleAssets: | 915.5000 |
| longTermInvestments: | 6591.8000 |
| inventories: | 2401.9000 |
| accountsReceivable: | 5328.7000 |
| accountsPayable: | 589.2000 |
| liabilitiesTotal: | 6550.5000 |
| longTermDebt: | 2701.4000 |
| shortTermDebt: | 0.0000 |
| commonStock: | 0.1000 |
| preferredStock: | 0.0000 |
| sales: | 12172.9000 |
| netIncome: | 4338.4000 |
| operatingResult: | 4738.9000 |
| incomeInterest: | -59.4000 |
| investments: | 3592.5000 |
| incomeTaxes: | 520.4000 |
| costGoodsSold: | 1560.4000 |
| grossProfit: | 10612.5000 |
| cashFlow: | 5014.9000 |
| cashFlowInvesting: | -3784.6000 |
| cashFlowFinancing: | -1009.0000 |
| cashFlowTotal: | 221.3000 |
| accountingStandard: | US GAAP |
| equityRatio: | 77.5779 |
| debtEquityRatio: | 28.9027 |
| liquidityI: | 98.8731 |
| liquidityII: | 268.5067 |
| netMargin: | 35.6398 |
| grossMargin: | 87.1814 |
| cashFlowMargin: | 41.1972 |
| ebitMargin: | 38.9299 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 21.4384 |
| preTaxROA: | 16.6315 |
| roe: | 19.1423 |
| roa: | 14.8502 |
| netIncomeGrowth: | -46.2757 |
| revenuesGrowth: | -24.2588 |
| taxExpenseRate: | 10.7105 |
| equityTurnover: | 0.5371 |
| epsBasic: | 40.5100 |
| epsDiluted: | 38.2200 |
| epsBasicGrowth: | -46.9764 |
| shareCapital: | 0.1000 |
| incomeBeforeTaxes: | 4858.8000 |
| priceEarningsRatioCompany: | 17.8102 |
| priceCashFlowRatio: | 15.4670 |
| bookValuePerShare: | 210.8134 |
| marketCap: | 77565503925.1400 |
| earningsYield: | 5.6148 |
| pegRatio: | -0.3791 |
| cashFlowPerShare: | 46.6470 |
| priceBookValueRatio: | 3.4224 |
| priceEarningsRatio: | 17.8788 |
| netEarningsPerShare: | 40.3544 |
| currency: | USD |
| year: | 2023 |
| priceEarningsRatioCompany: | 20.1150 |
| priceCashFlowRatio: | 17.4686 |
| bookValuePerShare: | 210.8134 |
| marketCap: | 88776539382.2400 |
| earningsYield: | 4.9714 |
| pegRatio: | -0.4282 |
| cashFlowPerShare: | 46.6470 |
| netAssetsPerShare: | 210.8134 |
| priceBookValueRatio: | 3.8653 |
| priceEarningsRatio: | 20.1926 |
| netEarningsPerShare: | 40.3544 |
| currency: | USD |
